Latest filing published 05 Oct 2017 for Kite Pharma, Inc.. Read the official filing
Roy Doumani is a declared insider of Kite Pharma, Inc., with filings sourced from SEC (Form 4). The record holds 14 filings, for trades running from 1 June 2016 to 3 October 2017.
Every open-market trade on record is a sale: 8 sales worth €3.2M. Other entries cover 2 share grants and 1 option exercise. In 2017 alone, the filings show no purchases and 5 sales.
The newest entry dates from 5 October 2017: a transaction, in Kite Pharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations